Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

MLA

Jordan, Emmet J., et al. “Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.” Cancer Discovery, vol. 7, no. 6, June 2017, pp. 596–609. EBSCOhost, https://doi.org/10.1158/2159-8290.CD-16-1337.

APA

Jordan, E. J., Kim, H. R., Arcila, M. E., Barron, D., Chakravarty, D., Gao, J., Chang, M. T., Ni, A., Kundra, R., Jonsson, P., Jayakumaran, G., Gao, S. P., Johnsen, H. C., Hanrahan, A. J., Zehir, A., Rekhtman, N., Ginsberg, M. S., Li, B. T., Yu, H. A., … Riely, G. J. (2017). Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. Cancer Discovery, 7(6), 596–609. https://doi.org/10.1158/2159-8290.CD-16-1337

Chicago

Jordan, Emmet J, Hyunjae R Kim, Maria E Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T Chang, et al. 2017. “Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.” Cancer Discovery 7 (6): 596–609. doi:10.1158/2159-8290.CD-16-1337.